- The correlation between income and weight in advanced countries is driven almost entirely by women. (The Economist) Recommended but gated.
- Canadians wait an average of 14.8 weeks between seeing a specialist and getting treatment at a cost of $2,925 per patient in lost wages and productivity.
- The top 1% now pay more in income taxes than the bottom 95%.
- In Virginia, hospitals must disclose their prices before patients are admitted. (WSJ)
- Harvard scientists: drug cocktail can reverse aging.
Category: Health Economics & Costs
Saturday Links
- Bernie Sanders has a new Medicare for All bill.
- Immortality may not be a blessing.
- Merritt Hawkins: The average wait time for new-patient to see a doctor is 26 days.
- CMS Proposal: Telehealth to Continue Unfettered Thru 2024. (InsideHealthPolicy)
- Social Security is already very progressive: An individual in the bottom fifth of lifetime earners receives a benefit equal to about 80% of their inflation-adjusted pre-retirement earnings. A middle quintile earner receives about 50%, while the top fifth receives 32%.
- Did Obamcare reduce the Disability Rolls? No.
- David Henderson: the reparations debate has everything backwards.
- Words of wisdom from Scott Sumner: The Fed doesn’t battle inflation, it creates inflation… The inflation we’ve experienced over the past few years is almost entirely created by a highly expansionary monetary policy, which drove up nominal GDP.
Friday Links
- We have been advocating OTC birth control for years.
- Adverse selection problems in insurance markets go away if people must insure by household rather than as individuals. At least in Pakistan.
- Is your doctor employed by a private equity firm? (NYT)
- AARP Represents Health Insurers, Not Seniors
- Is compression of morbidity being reversed? Considering 300 diseases in the USA from 1990 vs. 2017, health span (health-adjusted life expectancy) grew by 2 years, but life expectancy grew by 3 years.
- The Health Care Blog goes wacko: “The greatest health equity threat to Medicaid – and Medicare – beneficiaries is the climate crisis.”
FDA Finally Approved an OTC Oral Contraceptive; Now it Should Approved Competing Ones
The U.S. Food and Drug Administration has finally approved an over-the-counter hormonal birth control pill.
At a time of unrelenting attacks on reproductive autonomy, the Food and Drug Administration’s decision on July 13 to approve a birth control pill for over-the-counter (OTC) use is an important advance toward providing people with tools to control their fertility. This includes preventing unwanted pregnancy. Having Opill, a safe, effective, easy-to-use birth control option available without a prescription is essential, because it so difficult for many people to get prescription birth control in the U.S.